Synektik Spólka Akcyjna (WSE:SNT)

Market Cap	2.97B +38.7%
Revenue (ttm)	932.97M +49.7%
Net Income	418.07M +363.5%
EPS	49.02 +363.5%
Shares Out	8.53M
PE Ratio	6.74
Forward PE	13.51
Dividend	10.75 (3.08%)
Ex-Dividend Date	Jan 28, 2026

Volume	18,836
Open	346.40
Previous Close	346.80
Day's Range	344.20 - 351.40
52-Week Range	245.20 - 398.40
Beta	0.40
Analysts	Buy
Price Target	373.00 (+6.94%)
Est. Earnings	Dec 18, 2026

About Synektik Spólka Akcyjna

Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and nuclear medicine. It is also involved in development of IT solutions used in radiology, as well as research, produces, and sells radiopharmaceutical products used in diagnostics for oncology. In addition, it offers maintenance services for medical equipment, as well as acceptance and specialist tests. The company was founded in...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2001
• Employees: 239
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: SNT

Financial Performance

In fiscal year 2025, Synektik Spólka Akcyjna's revenue was 681.60 million, an increase of 9.21% compared to the previous year's 624.12 million. Earnings were 102.93 million, an increase of 24.66%.

Analyst Summary

According to 5 analysts, the average rating for SNT stock is "Buy." The 12-month stock price target is zł 373.00, which is an increase of 6.94% from the latest price.

Price Target

zł 373.00

(6.94% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 16, 2026

Data Sources Report a data error